PUBLISHER: GlobalData | PRODUCT CODE: 1395931
PUBLISHER: GlobalData | PRODUCT CODE: 1395931
Superabsorbents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within Wound Care Management therapeutic area.
The model discusses in detail the impact of COVID-19 on Superabsorbents market for the year 2020 and beyond. Chronic wounds are the main cause for treatments necessitating the use of superabsorbents. These dressings include pads which are used to absorb and retain fluid in moderate to highly exudating wounds. The high absorption capacity reduces the risk of leakage and minimizes the risk of maceration around the wound.
The market is expected to be driven by an increasing prevalence of chronic wounds and a rise in hospital acquired infections. Non-Antimicrobial superabsorbent are the key product currently being used as an alternative to traditional dressings and systemic antibiotics. The increase in surgical procedures, burn and trauma cases will exhibit an increase in usage of superabsorbents. Although antimicrobial superabsorbents are more expensive than other moist and traditional dressings, reduced treatment time and speedy recovery reduces the overall cost of the treatment.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Superabsorbents and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: 3M Co, Advancis Medical, BSN medical GmbH, Coloplast A/S, ConvaTec Group Plc, DeRoyal Industries Inc, Hollister Inc, Lohmann & Rauscher GmbH & Co. KG, Medline Industries LP, Molnlycke Health Care AB, Paul Hartmann AG, Smith & Nephew Plc, Urgo Ltd, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -